Stock PRE PRENETICS GLOBAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Prenetics Global Limited Share Price

Equities

PRE

KYG722451229

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
4.61 USD -7.24% Intraday chart for Prenetics Global Limited +58.97% -22.00%
04-01 Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023 CI
04-01 Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2023 - Sales 2024 * 35.2M 2.82B Capitalization 55.4M 4.44B
Net income 2023 * -48M -3.84B Net income 2024 * -47M -3.76B EV / Sales 2023 * 1.55 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 1.57 x
P/E ratio 2023 *
-0.22 x
P/E ratio 2024 *
-1.28 x
Employees 400
Yield 2023 *
-
Yield 2024 *
-
Free-Float 68.59%
More Fundamentals * Assessed data

Chart Prenetics Global Limited

Dynamic Chart

Latest news about Prenetics Global Limited

Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023 CI
Prenetics Global Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Prenetics Global Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Earnings Flash (PRE) PRENETICS LIMITED Reports Q4 Revenue $5.4M MT
Prenetics Global Enters Preliminary Agreement With Metavisionaries on Space Research MT
Prenetics Global Limited Announces Board Appointments CI
Earnings Flash (PRE) PRENETICS LIMITED Reports Q3 Revenue $4.9M MT
Prenetics Global Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cantor Fitzgerald Adjusts Prenetics Global Price Target to $4 From $6, Maintains Overweight Rating MT
Earnings Flash (PRE) PRENETICS LIMITED Reports Q2 Revenue $5.7M MT
Prenetics Global Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Traders Assess Russia Turmoil, Driving Quiet Premarket Action for US Equity Futures MT
Top Premarket Gainers MT
Prenetics Global Forms JV With Hong Kong University Professor for Multi-Cancer Early Detection Screening MT
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establishes USD 200 Million Joint Venture Insighta for Breakthrough Multi-Cancer Early Detection Screening CI
More news

Analyst Recommendations on Prenetics Global Limited

Cantor Fitzgerald Adjusts Prenetics Global Price Target to $4 From $6, Maintains Overweight Rating MT
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating AQ
Cantor Fitzgerald Initiates Prenetics Global at Overweight Rating With $7 Price Target MT
Citi Initiates Coverage on Prenetics Global with "Buy" Rating, Target Price at USD8.10 AQ
More recommendations

Press releases Prenetics Global Limited

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results AQ
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station AQ
PRENETICS GLOBAL : REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - Form 6-K PU
Prenetics Announces Third Quarter 2023 Financial Results AQ
Prenetics Global Limited Announces Reverse Stock Split GL
More press releases

Quotes and Performance

1 day-7.24%
1 week+58.97%
Current month+13.83%
1 month+29.49%
3 months-0.43%
6 months-20.17%
Current year-22.00%
More quotes

Highs and lows

1 week
2.95
Extreme 2.95
7.84
1 month
2.85
Extreme 2.85
7.84
Current year
2.85
Extreme 2.85
7.84
1 year
2.85
Extreme 2.85
15.90
3 years
2.85
Extreme 2.85
131.25
5 years
2.85
Extreme 2.85
131.25
10 years
2.85
Extreme 2.85
131.25
More quotes

Managers and Directors - Prenetics Global Limited

Managers TitleAgeSince
Chi Hung Tzang FOU
 Founder 50 31/12/13
Sheng Wu Yeung CEO
 Chief Executive Officer 45 31/12/13
Hoi Chun Lo DFI
 Director of Finance/CFO 39 31/12/17
Members of the board TitleAgeSince
Wing Kwan Chiu BRD
 Director/Board Member 44 17/05/22
Zhan Feng Cui BRD
 Director/Board Member 62 31/01/21
Sheng Wu Yeung CEO
 Chief Executive Officer 45 31/12/13
More insiders

Quotes

Date Price Change Volume
26/04/24 4.61 -7.24% 69,035
25/04/24 4.97 +3.76% 188,551
24/04/24 4.79 +4.81% 2,509,395
23/04/24 4.57 +24.18% 302,400
22/04/24 3.68 +26.90% 137,484

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes

Company Profile

Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The Company operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.
Sector
Biotechnology & Medical Research
Calendar
02/06/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Prenetics Global Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.61 USD
Average target price
9 USD
Spread / Average Target
+95.23%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
PRENETICS GLOBAL LIMITED Stock Prenetics Global Limited
-22.00% 55.4M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-20.45% 10.82B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+43.17% 3.25B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-35.86% 2.11B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-17.21% 2.08B
VERACYTE, INC. Stock Veracyte, Inc.
-29.81% 1.48B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.56% 1.02B
SEEGENE, INC. Stock Seegene, Inc.
-4.37% 733M
CAREDX, INC Stock CareDx, Inc
-37.00% 391M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 377M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. PRE Stock